IDE397: a novel MAT2A inhibitor in patients with solid tumors harboring MTAP deletions

Discovery of MTA-Cooperative PRMT5 Inhibitors for the Treatment of MTAP-Deleted Cancer.Подробнее

TranStar101: osemitamab, a novel CLDN18.2 inhibitor, in solid tumorsПодробнее

A novel ADC, AZD5335, for the treatment of solid tumorsПодробнее

How DNA methylation worksПодробнее

CLIATALK Series: Mindray Tumor Marker Total Solution and Laboratory Development SeminarПодробнее

Circulating Tumor Cell lines: tool for Translational Research | Protocol PreviewПодробнее

Phase I trial of NTX1088, a novel anti-PVR mAb, in solid tumorsПодробнее

Advances in the development of targeted therapies for renal cell carcinomaПодробнее

discovery of MRTX1719 for cancer indications - drug annotationsПодробнее

The Role of Targeting DNA Repair with PARPПодробнее

What effect does idasanutlin have on TP53-mutated clones in patients with polycythemia vera?Подробнее

Novel therapeutic approach to lethal SARS CoV 2 infection in aged murine modelsПодробнее

Blocking p120-catenin thwarts brain tumorsПодробнее

A Biomedical Anmiation of a Novel Therapeutic for Glioblastoma Tumor TreatmentПодробнее